Metformin News and Research

RSS
Metformin is the active ingredient in a drug used to treat diabetes mellitus (a condition in which the body cannot control the level of sugar in the blood). It is also being studied in the treatment of cancer. It decreases the amount of glucose (a type of sugar) released into the bloodstream from the liver and increases the body’s use of the glucose. Metformin is a type of antidiabetic agent.
Study identifies more than 200 new genes linked to depression

Study identifies more than 200 new genes linked to depression

New research project seeks to find innovative treatment pathways for Type 2 diabetes and obesity

New research project seeks to find innovative treatment pathways for Type 2 diabetes and obesity

How safe are GLP-1R agonists in early pregnancy?

How safe are GLP-1R agonists in early pregnancy?

Adherence to second-line drugs for Type 2 diabetes can be hit or miss, study reports

Adherence to second-line drugs for Type 2 diabetes can be hit or miss, study reports

The influence of vitamin supplementation on longitudinal patterns of maternal vitamin status from preconception to post-delivery

The influence of vitamin supplementation on longitudinal patterns of maternal vitamin status from preconception to post-delivery

A class of diabetes medications may reduce the risk of colorectal cancer

A class of diabetes medications may reduce the risk of colorectal cancer

Simple bean diet intervention demonstrates significant prebiotic effects

Simple bean diet intervention demonstrates significant prebiotic effects

Brown seaweed emerges as a potent ally in diabetes control

Brown seaweed emerges as a potent ally in diabetes control

New adaptive clinical trial aims to reverse neurological damage caused by progressive multiple sclerosis

New adaptive clinical trial aims to reverse neurological damage caused by progressive multiple sclerosis

Hevolution-AFAR New Investigator Awards expanded with $16 million grant

Hevolution-AFAR New Investigator Awards expanded with $16 million grant

New study reveals increased cancer risk linked to higher BMI in adults with cardiovascular diseases

New study reveals increased cancer risk linked to higher BMI in adults with cardiovascular diseases

Probiotics paired with metformin could be a game-changer in type 2 diabetes control

Probiotics paired with metformin could be a game-changer in type 2 diabetes control

Citrus compounds show zesty promise in type 2 diabetes management

Citrus compounds show zesty promise in type 2 diabetes management

Stopping metformin early linked to higher dementia risk in older adults with type 2 diabetes

Stopping metformin early linked to higher dementia risk in older adults with type 2 diabetes

NF-κB activation during COVID-19 and its impact on patients with hypertension

NF-κB activation during COVID-19 and its impact on patients with hypertension

Study highlights ways to identify children at high risk of type 2 diabetes and prevention strategies

Study highlights ways to identify children at high risk of type 2 diabetes and prevention strategies

International report paves way for precision diabetes medicine breakthrough

International report paves way for precision diabetes medicine breakthrough

Early metformin therapy falls short in curbing gestational diabetes woes

Early metformin therapy falls short in curbing gestational diabetes woes

Could a mushroom-derived product be the future of lung cancer prevention?

Could a mushroom-derived product be the future of lung cancer prevention?

Breast cancer patients treated with alpelisib have elevated rates of high blood sugar

Breast cancer patients treated with alpelisib have elevated rates of high blood sugar

While we only use edited and approved content for Azthena answers, it may on occasions provide incorrect responses. Please confirm any data provided with the related suppliers or authors. We do not provide medical advice, if you search for medical information you must always consult a medical professional before acting on any information provided.

Your questions, but not your email details will be shared with OpenAI and retained for 30 days in accordance with their privacy principles.

Please do not ask questions that use sensitive or confidential information.

Read the full Terms & Conditions.